US drug industry's claims of other countries “freeloading” are a myth

BMJ 2005; 330 doi: http://dx.doi.org/10.1136/bmj.330.7484.165 (Published 20 January 2005)
Cite this as: BMJ 2005;330:165.1

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Ray Moynihan
  1. Sydney

    A member of George Bush's Presidential Business Commission—a group of business and professional people who are advising the president on the next election—has launched a scathing attack on the US pharmaceutical industry and on the industry's claims that other countries are damaging drug development by paying lower prices.

    Delivering the David Rogers lecture at Cornell Medical College in New York last month, bioethicist Donald Light said no evidence existed to support the view that European nations were “freeloading” and that the current US attempts to raise prices through free-trade agreements with other countries were simply designed to boost profits, not …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL